PRESS RELEASE published on 08/13/2024 at 09:00, 1 year 9 months ago Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study Eckert & Ziegler SE partners with Telix Pharmaceuticals for ProstACT GLOBAL Phase III study, serving as European CMO and supplier of Lu-177, aiming to advance prostate cancer treatment Eckert & Ziegler Telix Pharmaceuticals Radiopharmaceuticals Phase III Study ProstACT GLOBAL
BRIEF published on 08/09/2024 at 07:50, 1 year 9 months ago Eckert & Ziegler Achieves Significant Growth in First Half of 2024 Sales Increase Financial Forecast Earnings Growth Medical Segment Isotope Products
PRESS RELEASE published on 08/09/2024 at 07:45, 1 year 9 months ago Eckert & Ziegler Continues Sales and Earnings Growth in the First Half of 2024 Eckert & Ziegler SE reports continued sales and earnings growth in the first half of 2024. Sales up by 23% to €145.4 million, EBIT rose to €32.5 million Financial Results Sales Growth 2024 Earnings Growth Eckert & Ziegler SE
BRIEF published on 08/05/2024 at 15:50, 1 year 9 months ago Eckert & Ziegler Expands GalliaPharm® Availability Across EEA Nuclear Medicine GalliaPharm® EEA Approval Radionuclide Generators Cost-effective Diagnostics
PRESS RELEASE published on 08/05/2024 at 15:45, 1 year 9 months ago Eckert & Ziegler extends GalliaPharm® availability to the entire European Economic Area Eckert & Ziegler SE extends availability of GalliaPharm® to the entire European Economic Area after receiving EC approval, offering cost-effective radiolabeling solution for PET diagnostics Eckert & Ziegler SE European Economic Area GalliaPharm® EC Approval Radiolabeling
BRIEF published on 07/16/2024 at 14:31, 1 year 10 months ago Eckert & Ziegler Increases Sales and Earnings, Raises Profit Forecast for 2024 Sales Growth Eckert & Ziegler EBIT Profit Forecast 2024 Financial Results
PRESS RELEASE published on 07/16/2024 at 14:26, 1 year 10 months ago EQS-Adhoc: Eckert & Ziegler Again Increases Sales and Earnings Compared to Previous Year. Profit Forecast Raised for 2024. Eckert & Ziegler SE reports impressive sales and earnings growth in the first half of 2024. Profit forecast raised for 2024 Sales Growth Earnings Increase Profit Forecast Eckert & Ziegler SE 2024 Financial Results
BRIEF published on 06/26/2024 at 16:32, 1 year 11 months ago Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG Annual General Meeting Dividend Eckert & Ziegler Pentixapharm AG Corporate Split-Off
PRESS RELEASE published on 06/26/2024 at 16:27, 1 year 11 months ago Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG The Annual General Meeting of Eckert & Ziegler SE has approved the split-off of Pentixapharm AG and declared a dividend of EUR 0.05 per share for 2023 Annual General Meeting Dividend Eckert & Ziegler SE Pentixapharm AG Split-off
BRIEF published on 06/25/2024 at 12:05, 1 year 11 months ago Eckert & Ziegler Subsidiary Pentixapharm Receives FDA Feedback to Initiate Phase III Trial with PentixaFor Pentixapharm FDA Phase III Trial Ga68-PentixaFor Primary Aldosteronism Radiopharmaceutical Diagnostic
Published on 05/27/2026 at 15:25, 5 hours 39 minutes ago LaFleur Announces Upsize of Bought Deal Equity Offerings for Gross Proceeds of C$10 Million
Published on 05/27/2026 at 15:22, 5 hours 42 minutes ago AmeriTrust Announces First Quarter 2026 Financial Results
Published on 05/27/2026 at 15:15, 5 hours 49 minutes ago Storm Exploration Begins Field Program on VMS Target at Gold Standard
Published on 05/27/2026 at 15:00, 6 hours 4 minutes ago Jaguar Health Compliant with Nasdaq Bid Price Rule
Published on 05/27/2026 at 14:49, 6 hours 15 minutes ago Sekur Private Data Signs Defense Distribution Agreement with Elyon International, Marking Strategic Shift to Defense, Government and Enterprise Communications
Published on 05/27/2026 at 20:52, 11 minutes ago EQS-Adhoc: REPLOID Group AG: Procedural deficiencies related to the appointment of auditors in prior periods require remediation. Publication of the 2025 Annual Statements delayed.
Published on 05/27/2026 at 20:32, 31 minutes ago Sirma Group Holding AD reports strong profitability growth in Q1 2026
Published on 05/27/2026 at 19:55, 1 hour 8 minutes ago IGEL Brings Now & Next Workspace & Endpoint Security Summits to Five European Cities
Published on 05/27/2026 at 19:10, 1 hour 53 minutes ago 124th Annual General Meeting of Romande Energie Holding SA
Published on 05/27/2026 at 17:45, 3 hours 19 minutes ago Imerys-05-2026-information-share-capital-and-voting-rights-as-of-30-April-2026
Published on 05/27/2026 at 17:45, 3 hours 19 minutes ago Description of Share buyback program - May 2026
Published on 05/27/2026 at 17:45, 3 hours 19 minutes ago Report on share repurchases from 20 to 26 May 2026
Published on 05/27/2026 at 17:45, 3 hours 19 minutes ago Report ordinary & special general meeting of May 27, 2026
